New Issue: ProMetic raises C$15 million in share offering

Nashville, June 17 - ProMetic Life Sciences Inc. announced Friday that it has closed on a C$15 million financing with the sale of 30 million subordinated voting shares at 50 cents each via lead agent Paradigm Capital Inc.

Co-managers of the offering were Sprott Securities Inc., First Associates Investments Inc. and Octagon Capital Corp.

"Given current market conditions, this financing is a strong endorsement of our growth opportunities in both our therapeutic and enabling technology business units," said Pierre Laurin, chief executive of ProMetic. "This transaction was completed with the strong support of existing and new investors, including the participation of 14 financial institutions across North America."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.